TY  - CONF

T1  - Nab-paclitaxel or docetaxel; as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): cost utility analysis from the perspective of the United Kingdom (UK)

JO  - EJC SUPPLEMENTS

PY  - 2008/04/01

AU  - Dranitsaris G

AU  - Lidgren M

AU  - Lundkvist J

AU  - Coleman R

ED  - 

VL  - 6

IS  - 7

SP  - 67

EP  - 67

Y2  - 2025/10/10

ER  -